NASDAQ
Celldex Therapeutics, Inc. (CLDX) has a current ratio of 10.49x as of Monday, May 25, 2026. This represents a 43.86% decrease compared to its 12-month average of 18.68x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.